Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Heilongjiang University of Chinese MedicineNo recent work listed

Lili Zhong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7834-4629; OpenAlex author ID A5075108785. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper

Papers 2

  1. Dauricine suppresses the growth of pancreatic cancer in vivo by modulating the Hedgehog signaling pathway. Last author DOI 10.3892/ol.2019.10790↗
  2. Phenolic alkaloids from Menispermum dauricum inhibits BxPC-3 pancreatic cancer cells by blocking of Hedgehog signaling pathway. Co-author DOI 10.4103/0973-1296.165548↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yingbo Zhang · 1 shared paper, 2019 · strength 0.11
  2. Shuliang Wu · 1 shared paper, 2019 · strength 0.11
  3. Yun Bai · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.